CDR Administrative Supplement for COVID-19 Impacted NIMH Research

针对受新冠肺炎 (COVID-19) 影响的 NIMH 研究的 CDR 行政补充

基本信息

项目摘要

ABSTRACT Significance: As recent national controversy over Joint Commission mandates proves, universal suicide risk screening in emergency departments (ED) will not achieve widespread adoption because confusion remains around which specific risk indicators to assess, and clinicians fear that such screening will lead to massive surges in psychiatric evaluations. To address these two implementation barriers, this study was funded to derive a clinical decision rule to support universal risk detection and optimize patient care workflow in adults. Investigators: The Project Team has extensive expertise in ED-based suicide risk screening and assessment (Boudreaux, Larkin), clinical decision rule design (Boudreaux, Stiell), predictive analytics (Wang, Liu, Simon), machine learning and informatics (Liu, Simon), industrial engineering (Johnson), and healthcare economics (Clements). A Clinical Advisory Panel ensures that the proposal is grounded in the practical realities of the ED. Innovation: The study will be the first to apply industry standards for deriving decision rules to suicide risk and will directly inform the controversy regarding the relative strengths and weaknesses of universal versus targeted screening. We will pioneer new statistical innovations for rule derivation and will integrate simulation of potential workflow impact using industrial engineering modeling and economic analyses. Approach: We have developed a pool of empirically supported clinician-acceptable candidate suicide risk indicators. Data on these candidate indicators are being collected by trained research staff on adult medical and psychiatric patients from a large ED. Participants are undergoing a comprehensive suicide risk assessment by a research clinician, blinded to the indicators, who assigns the participant to a criterion reference risk group: Negligible, Mild-Moderate, or High risk. Participants are being followed for 24 weeks after the visit to assess suicidal behavior, our secondary outcome. In Aim 1, we will derive a universal screening decision rule for “all comers,” as well as a variant to be used with patients presenting with a psychiatric chief complaint (targeted). In Aim 2, we will test whether a previously validated risk stratification algorithm using data from the electronic health record improves the performance of the decision rules. In Aim 3, we will model the potential operational impact of the rules through dynamic modeling of clinical workflow and economic costs and assessing clinician and patient acceptability in a new sample of 100 ED clinician-patient dyads. Environment: UMass has demonstrated its capability to support this study through several key preliminary studies, including the ED-SAFE studies, System of Safety, and other suicide-related studies set in the ED. Impact: By providing clear, evidence-based recommendations on universal screening and optimized workflow using standards accepted by emergency clinicians, this study will address two pivotal barriers to universal suicide risk screening, transforming the “right thing” into the “easy thing” so it becomes the “usual thing.”
摘要 意义:正如最近关于联合委员会授权的全国性争议所证明的那样,普遍的自杀风险 急诊科(ED)的筛查不会得到广泛采用,因为混乱仍然存在 围绕哪些特定的风险指标进行评估,临床医生担心这样的筛查将导致大规模 精神病学评估的激增。为了解决这两个实施障碍,这项研究的资金来源是 得出临床决策规则,以支持普遍的风险检测并优化成人患者护理工作流程。 调查人员:项目团队在基于ED的自杀风险筛查和评估方面拥有丰富的专业知识 (Boudreaux,Larkin),临床决策规则设计(Boudreaux,Stiell),预测分析(Wang,Liu,Simon), 机器学习和信息学(Liu,Simon)、工业工程(Johnson)和医疗保健经济学 (克莱门茨)临床顾问团确保有关建议切合教育署的实际情况。 创新:这项研究将首次将行业标准应用于自杀风险和自杀风险的决策规则 将直接引出关于宇宙与宇宙相对强弱的争论 有针对性的筛查。我们将在规则推导方面开创新的统计创新,并将整合模拟 使用工业工程建模和经济分析来评估潜在的工作流程影响。 方法:我们已经开发了一组经验支持的临床医生可接受的候选自杀风险 指标。这些候选指标的数据是由训练有素的成人医学研究人员收集的 以及来自大型急诊室的精神病患者。参与者正在经历全面的自杀风险 研究临床医生的评估,对指标视而不见,给参与者分配一个标准 参考风险组:可忽略、轻度-中度或高度风险。参与者将在24周后接受跟踪 这次访问是为了评估自杀行为,这是我们的次要结果。在目标1中,我们将推导出一种普遍筛查 “所有来者”的决定规则,以及一个变种,用于患者向精神病科主任提交报告 投诉(有针对性)。在目标2中,我们将测试先前验证的风险分层算法是否使用 来自电子健康记录的数据改进了决策规则的性能。在目标3中,我们将建模 通过对临床工作流程和经济成本进行动态建模,这些规则可能产生的操作影响 以及评估临床医生和患者对100名ED临床医生-患者二人组的新样本的可接受性。 环境:马萨诸塞州大学通过几个关键的初步研究证明了它有能力支持这项研究 研究,包括ED-SAFE研究、安全系统,以及在ED设置的其他与自杀有关的研究。 影响:通过提供关于普遍筛查和优化工作流程的清晰、循证的建议 使用急诊医生接受的标准,这项研究将解决普及的两个关键障碍 自杀风险筛查,把“正确的事情”变成“容易的事情”,这样它就变成了“平常的事情”。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Edwin D Boudreaux其他文献

Edwin D Boudreaux的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Edwin D Boudreaux', 18)}}的其他基金

Signature Research Project
签名研究项目
  • 批准号:
    10577120
  • 财政年份:
    2023
  • 资助金额:
    $ 29.49万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10577118
  • 财政年份:
    2023
  • 资助金额:
    $ 29.49万
  • 项目类别:
The Center for Accelerating Practices to End Suicide through Technology Translation (CAPES)
通过技术转化加速结束自杀实践中心 (CAPES)
  • 批准号:
    10577117
  • 财政年份:
    2023
  • 资助金额:
    $ 29.49万
  • 项目类别:
Telehealth to Improve Prevention of Suicide (TIPS) in EDs
远程医疗可改善急诊科的自杀预防 (TIPS)
  • 批准号:
    10322028
  • 财政年份:
    2021
  • 资助金额:
    $ 29.49万
  • 项目类别:
Telehealth to Improve Prevention of Suicide (TIPS) in EDs
远程医疗可改善急诊科的自杀预防 (TIPS)
  • 批准号:
    10532210
  • 财政年份:
    2021
  • 资助金额:
    $ 29.49万
  • 项目类别:
Reward-based technology to improve opioid use disorder treatment initiation after an ED visit
基于奖励的技术可改善急诊就诊后阿片类药物使用障碍治疗的启动
  • 批准号:
    10414138
  • 财政年份:
    2019
  • 资助金额:
    $ 29.49万
  • 项目类别:
Computerized Adaptive Suicidal Risk Stratification and Prediction
计算机化自适应自杀风险分层和预测
  • 批准号:
    10254382
  • 财政年份:
    2019
  • 资助金额:
    $ 29.49万
  • 项目类别:
Reward-based technology to improve opioid use disorder treatment initiation after an ED visit
基于奖励的技术可改善急诊就诊后阿片类药物使用障碍治疗的启动
  • 批准号:
    10337501
  • 财政年份:
    2019
  • 资助金额:
    $ 29.49万
  • 项目类别:
Reward-based technology to improve opioid use disorder treatment initiation after an ED visit
基于奖励的技术可改善急诊就诊后阿片类药物使用障碍治疗的启动
  • 批准号:
    10794875
  • 财政年份:
    2019
  • 资助金额:
    $ 29.49万
  • 项目类别:
Deriving a Clinical Decision Rule for Suicide Risk in the Emergency Department Setting
得出急诊科自杀风险的临床决策规则
  • 批准号:
    10299606
  • 财政年份:
    2019
  • 资助金额:
    $ 29.49万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 29.49万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.49万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 29.49万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.49万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 29.49万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 29.49万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.49万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 29.49万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 29.49万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.49万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了